Information Library
Thought leadership - Market Access
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Rewarding Innovation and Value: What is the Role of Comparative Effectiveness Research
October 6, 2009
The impact of comparative effectiveness research on the future of drug development. -
Comparative Effectiveness Research as a Drug Development Tool
September 1, 2009
A Q&A with John Doyle, Vice President and Practice Leader of Quintiles Consulting, sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development. -
A New Gold Standard for Pricing
September 26, 2008
Dr. John Doyle, practice leader for market access at Quintiles Consulting, introduces the concept of a health economic balance sheet and evidence-based pricing for biopharmaceutical valuation.
Page 1 of 1 (3 items)